Sildenafil 10 MG/ML Oral Suspension [Revatio] — RxCUI 1307431
RxNorm drug concept · Semantic branded drug
RxCUI 1307431
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1307431
Official nameSildenafil 10 MG/ML Oral Suspension [Revatio]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRevatio 10 MG/ML Oral Suspension; Revatio 10 MG in 1 mL Oral Suspension; Revatio (as sildenafil citrate) 10 MG/ML Powder for Oral Suspension; Revatio 10 MG per 1 ML Oral Suspension
FDA products mapped4
Package NDCs mapped3
Reported Medicaid activity (SDUD)485 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sildenafil: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- For erectile dysfunction, you take sildenafil only when you need it — about 30 minutes to 1 hour before sexual activity works best, though anywhere from 30 minutes to 4 hours ahead...
- Can I take Viagra or generic sildenafil just before sex, or do I need to take it every day?
- Both sildenafil and nitrates lower blood pressure, and together their effect on blood pressure can be dangerously large — we're talking about a drop severe enough to cause fainting...
- Why can't I take sildenafil with nitroglycerin or other nitrate medicines?
🕸️ Concept Web — How Sildenafil 10 MG/ML Oral Suspension [Revatio] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sildenafil 10 MG/ML Oral Suspension [Revatio]
RxCUI 1307431 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Sildenafil
136411IN
-
Sildenafil
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Revatio
581642BN
-
Revatio
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sildenafil Oral Suspension
1307426SCDF -
Sildenafil Oral Liquid Product
1307425SCDG -
Sildenafil Oral Product
1159091SCDG -
Sildenafil Oral Suspension [Revatio]
1307429SBDF -
Revatio Oral Liquid Product
1307430SBDG -
Revatio Oral Product
1182547SBDG -
Oral Suspension
316969DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Sildenafil Oral Suspension
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sildenafil 10 MG/ML Oral Suspension
1307427SCD -
Sildenafil 10 MG/ML
1307424SCDC -
Sildenafil 10 MG/ML [Revatio]
1307428SBDC
-
Sildenafil 10 MG/ML Oral Suspension
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sildenafil 10 MG/ML Oral Suspension
SCD · 1307427 -
Sildenafil 10 MG/ML
SCDC · 1307424 -
Sildenafil Oral Suspension
SCDF · 1307426 -
Sildenafil Oral Liquid Product
SCDG · 1307425 -
Sildenafil Oral Product
SCDG · 1159091
Brand-Name Concepts
-
Sildenafil 10 MG/ML [Revatio]
SBDC · 1307428 -
Sildenafil Oral Suspension [Revatio]
SBDF · 1307429 -
Revatio Oral Liquid Product
SBDG · 1307430 -
Revatio Oral Product
SBDG · 1182547 -
Revatio
BN · 581642
📦 FDA Products & Package NDCs
4 products · 3 package NDCs
3 package NDCs map to RxCUI 1307431 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00069-4190-68 | 90 TABLET, FILM COATED in 1 BOTTLE (0069-4190-68) | Revatio | PFIZER LABORATORIES DIV PFIZER INC | 2005-06-03 |
| 58151-0395-31 | 1 VIAL in 1 CARTON (58151-395-31) / 12.5 mL in 1 VIAL | Revatio | Viatris Specialty LLC | 2025-04-09 |
| 58151-0402-77 | 90 TABLET, FILM COATED in 1 BOTTLE (58151-402-77) | Revatio | Viatris Specialty LLC | 2026-06-22 |
Observed labelers:
Viatris Specialty LLC (2) ·
PFIZER LABORATORIES DIV PFIZER INC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.